HomeLVTX • NASDAQ
add
LAVA Therapeutics NV
Previous close
$2.84
Day range
$2.90 - $3.05
Year range
$1.13 - $6.47
Market cap
78.87M USD
Avg Volume
219.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 353.00K | -86.63% |
Operating expense | 5.64M | -60.05% |
Net income | -6.50M | 56.43% |
Net profit margin | -1.84K | -225.83% |
Earnings per share | -0.22 | 57.95% |
EBITDA | -5.26M | 53.42% |
Effective tax rate | -0.95% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 95.57M | -28.07% |
Total assets | 101.71M | -29.08% |
Total liabilities | 50.53M | -11.94% |
Total equity | 51.18M | — |
Shares outstanding | 26.29M | — |
Price to book | 1.46 | — |
Return on assets | -12.79% | — |
Return on capital | -23.00% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.50M | 56.43% |
Cash from operations | -10.12M | -128.32% |
Cash from investing | -8.69M | -109.88% |
Cash from financing | -180.00K | -1,025.00% |
Net change in cash | -18.43M | -151.20% |
Free cash flow | -8.17M | -120.32% |
About
CEO
Founded
2016
Website
Employees
37